LEXINGTON, Mass.--(BUSINESS WIRE)--Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) continues to leverage its powerful CUBICIN patient registry and experience database known by the acronym CORE. In September, the database registered its 5,000th patient entry.
